Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zevra Therapeutics Inc (ZVRA)

Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zevra Therapeutics Inc 1180 CELEBRATION BOULEVARD SUITE 103 CELEBRATION FL 34747 USA

https://zevra.com Employees: 69 P: 321-939-3416

Description:

Zevra Therapeutics is a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options. Zevra Therapeutics, formerly known as KemPharm Inc., is based in CELEBRATION, Fla.

Key Statistics

Overview:

Market Capitalization, $K 478,783
Enterprise Value, $K 478,503
Shares Outstanding, K 53,376
Annual Sales, $ 27,460 K
Annual Net Income, $ -46,050 K
Last Quarter Sales, $ 3,700 K
Last Quarter Net Income, $ -33,230 K
EBIT, $ -81,640 K
EBITDA, $ -80,630 K
60-Month Beta 1.93
% of Insider Shareholders 2.40%
% of Institutional Shareholders 35.03%
Float, K 52,095
% Float 97.60%
Short Volume Ratio 0.47

Growth:

1-Year Return 105.21%
3-Year Return 11.43%
5-Year Return 24.58%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 96.74%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.69 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -1.97
EPS Growth vs. Prev Qtr -43.75%
EPS Growth vs. Prev Year -72.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 12/28/20

ZVRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -159.54%
Return-on-Assets % -51.50%
Profit Margin % -167.70%
Debt/Equity 0.84
Price/Sales 17.44
Price/Cash Flow N/A
Price/Book 6.76
Book Value/Share 1.33
Interest Coverage -29.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar